Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Phase 3 is much bigger catalyst than phase 2, only 8% of drugs...

First 11861 Last

Share
Profile

Follow
DaveFisher

201 Posts.

84

29/01/22

22:41

Post #: 59216846
Share

Originally posted by FreeBobby2002: ↑

I actually think phase 2 trials are a bigger catalyst than phase 3 for shareholders specifically. By the time you're doing phase 3, you already know that the drug is safe and works in humans. Whereas phase 2 answers the yes/no question around whether it works in humans or not which is the main thing. I believe the success rate for phase 2 is the lowest of all the phases.

IIRC, not uncommon for pharma buyouts to be in the phase 1/2 stage. The Big pharma companies have the size, scale, expertise with dealing with regulators etc to run the big phase 3 trials.

Expand

Phase 3 is much bigger catalyst than phase 2, only 8% of drugs pass phase 3
i encourage everyone to google search phase 3
on the overall market side, things could get worse
https://www.cnbc.com/2022/01/28/big-swings-in-the-market-are-more-normal-than-investors-might-expect.html

IHL Price at posting: 45.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

FEX

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

AL8

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

CC9

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

SXG

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

There are more pages in this discussion • 8,009 more messages in this thread...

First 11861 Last

Add IHL (ASX) to my watchlist

SPONSORED BY